Search - tctmd.com

Displaying 41 - 60 of 1031

Sort: Relevancy | Date

Presentation TCT 2024

TCT 371: Post Market Study of the FANTOM Sirolimus-Eluting Bioresorbable Coronary Scaffold: Long Term Clinical Outcomes

Presenter: Matthias Lutz

October 29, 2024

Presentation TCT 2024

TCT 365: Ten-Year Outcomes Following Bioresorbable Vascular Scaffold Implantation in Patients With De Novo Occlusive Coronary Artery Disease

Presenter: Marta Mazur

October 29, 2024

Presentation TCT 2024

TCT 1011: Drug-Eluting Stent or Bioresorbable Vascular Scaffold for Preventive PCI: Post-Hoc Analysis From the PREVENT Trial

Presenter: Han Su Park

October 28, 2024

Presentation TCT 2024

TCT 421: Ultrathin Bioresorbable Polymer Sirolimus-Eluting Stents in U.S. Patients Undergoing Coronary Revascularization: 2-Year Outcomes From the BIOFLOW-VII Trial

Presenter: David Kandzari

October 28, 2024

Presentation TCT 2024

TCT 394: Peripheral Bioresorbable Scaffold Made by Multi-Axial Extrusion Technology: New Material, Design and First-in-Human Experience

Presenter: Yuxian Luo

October 27, 2024

Presentation TCT 2024

TCT 362: Optimal Pre-Dilatation Treatment Before Implantation of a Magmaris Bioresorbable Scaffold in Coronary Artery Stenosis: The OPTIMIS Trial

Presenter: Kirstine Hansen

October 27, 2024

Presentation TCT 2024

TCT 363: Five-Year Clinical Outcomes of Patients Treated With the XINSORB Bioresorbable Sirolimus-Eluting Scaffolds

Presenter: Jiasheng Yin

October 27, 2024

Presentation TCT 2024

TCT 364: FANTOM II Long Lesion Study: Initial Safety & Performance Study of the Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold in Long Lesions: 5 Clinical Year Outcomes

Presenter: Matthias Lutz

October 27, 2024

News Conference News ESC 2024

‘Unlocking’ Scaffold Matches DES in Wide Range of PCI Patients, Including ACS

Michael O'Riordan

September 09, 2024

News Daily News

DES Best for In-Stent Restenosis, but DCBs Also Viable

Michael O'Riordan

August 13, 2024

News Daily News

FDA Medical Devices Chief Jeff Shuren Announces Retirement

L.A. McKeown

July 24, 2024

News Conference News EuroPCR 2024

Solid 2-Year Data With ‘Unlocking’ Coronary Stent: BIOADAPTOR RCT

Michael O'Riordan

May 28, 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for April 2024

Shelley Wood

April 30, 2024

News Daily News

FDA Approves Bioresorbable Scaffold for BTK Lesions

Michael O'Riordan

April 29, 2024

News Conference News ACC 2024

PREVENT Supports Early PCI for Vulnerable Plaque, With Reductions in MACE

L.A. McKeown

April 08, 2024

News Opinion Off Script

Evoque and Patisiran: A Tale of Two Regulatory Journeys

Sanjay Kaul, MD

March 29, 2024

News Conference News ISET 2024

Will IVUS Ever Take Off in Peripheral Vascular Interventions?

Caitlin E. Cox

January 31, 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2023

Shelley Wood

November 01, 2023

Presentation TCT 2023

TCT 817: ABSORB bioresorbable scaffold (BRS) late restenosis treated with novel Magmaris BRS

Presenter: Jorgo Kostov

October 25, 2023

News Conference News TCT 2023

LIFE-BTK: Bioresorbable Scaffold Holds Promise for Infrapopliteal CLTI

L.A. McKeown

October 25, 2023

Advertisement

TCT 371: Post Market Study of the FANTOM Sirolimus-Eluting Bioresorbable Coronary Scaffold: Long Term Clinical Outcomes

TCT 365: Ten-Year Outcomes Following Bioresorbable Vascular Scaffold Implantation in Patients With De Novo Occlusive Coronary Artery Disease

TCT 1011: Drug-Eluting Stent or Bioresorbable Vascular Scaffold for Preventive PCI: Post-Hoc Analysis From the PREVENT Trial

TCT 421: Ultrathin Bioresorbable Polymer Sirolimus-Eluting Stents in U.S. Patients Undergoing Coronary Revascularization: 2-Year Outcomes From the BIOFLOW-VII Trial

TCT 394: Peripheral Bioresorbable Scaffold Made by Multi-Axial Extrusion Technology: New Material, Design and First-in-Human Experience

TCT 362: Optimal Pre-Dilatation Treatment Before Implantation of a Magmaris Bioresorbable Scaffold in Coronary Artery Stenosis: The OPTIMIS Trial

TCT 363: Five-Year Clinical Outcomes of Patients Treated With the XINSORB Bioresorbable Sirolimus-Eluting Scaffolds

TCT 364: FANTOM II Long Lesion Study: Initial Safety & Performance Study of the Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold in Long Lesions: 5 Clinical Year Outcomes

‘Unlocking’ Scaffold Matches DES in Wide Range of PCI Patients, Including ACS

DES Best for In-Stent Restenosis, but DCBs Also Viable

FDA Medical Devices Chief Jeff Shuren Announces Retirement

Solid 2-Year Data With ‘Unlocking’ Coronary Stent: BIOADAPTOR RCT

TCTMD’s Top 10 Most Popular Stories for April 2024

FDA Approves Bioresorbable Scaffold for BTK Lesions

PREVENT Supports Early PCI for Vulnerable Plaque, With Reductions in MACE

Evoque and Patisiran: A Tale of Two Regulatory Journeys

Will IVUS Ever Take Off in Peripheral Vascular Interventions?

TCTMD’s Top 10 Most Popular Stories for October 2023

TCT 817: ABSORB bioresorbable scaffold (BRS) late restenosis treated with novel Magmaris BRS

LIFE-BTK: Bioresorbable Scaffold Holds Promise for Infrapopliteal CLTI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content